BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 7836845)

  • 1. Cancer risks in A-T heterozygotes.
    Easton DF
    Int J Radiat Biol; 1994 Dec; 66(6 Suppl):S177-82. PubMed ID: 7836845
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Breast and other cancers in families with ataxia-telangiectasia.
    Swift M; Reitnauer PJ; Morrell D; Chase CL
    N Engl J Med; 1987 May; 316(21):1289-94. PubMed ID: 3574400
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cancer risks and mortality in heterozygous ATM mutation carriers.
    Thompson D; Duedal S; Kirner J; McGuffog L; Last J; Reiman A; Byrd P; Taylor M; Easton DF
    J Natl Cancer Inst; 2005 Jun; 97(11):813-22. PubMed ID: 15928302
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Incidence of cancer in 161 families affected by ataxia-telangiectasia.
    Swift M; Morrell D; Massey RB; Chase CL
    N Engl J Med; 1991 Dec; 325(26):1831-6. PubMed ID: 1961222
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cancer in patients with ataxia-telangiectasia and in their relatives in the nordic countries.
    Olsen JH; Hahnemann JM; Børresen-Dale AL; Brøndum-Nielsen K; Hammarström L; Kleinerman R; Kääriäinen H; Lönnqvist T; Sankila R; Seersholm N; Tretli S; Yuen J; Boice JD; Tucker M
    J Natl Cancer Inst; 2001 Jan; 93(2):121-7. PubMed ID: 11208881
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cancer risk in heterozygotes for ataxia-telangiectasia.
    Geoffroy-Perez B; Janin N; Ossian K; Laugé A; Croquette MF; Griscelli C; Debré M; Bressac-de-Paillerets B; Aurias A; Stoppa-Lyonnet D; Andrieu N
    Int J Cancer; 2001 Jul; 93(2):288-93. PubMed ID: 11410879
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Health risks for ataxia-telangiectasia mutated heterozygotes: a systematic review, meta-analysis and evidence-based guideline.
    van Os NJ; Roeleveld N; Weemaes CM; Jongmans MC; Janssens GO; Taylor AM; Hoogerbrugge N; Willemsen MA
    Clin Genet; 2016 Aug; 90(2):105-17. PubMed ID: 26662178
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of ataxia-telangiectasia heterozygotes in familial breast cancer.
    Chen J; Birkholtz GG; Lindblom P; Rubio C; Lindblom A
    Cancer Res; 1998 Apr; 58(7):1376-9. PubMed ID: 9537233
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Breast cancer risk in ataxia telangiectasia (AT) heterozygotes: haplotype study in French AT families.
    Janin N; Andrieu N; Ossian K; Laugé A; Croquette MF; Griscelli C; Debré M; Bressac-de-Paillerets B; Aurias A; Stoppa-Lyonnet D
    Br J Cancer; 1999 Jun; 80(7):1042-5. PubMed ID: 10362113
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk of breast cancer and other cancers in heterozygotes for ataxia-telangiectasia.
    Inskip HM; Kinlen LJ; Taylor AM; Woods CG; Arlett CF
    Br J Cancer; 1999 Mar; 79(7-8):1304-7. PubMed ID: 10098776
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cancers in 44 families with ataxia-telangiectasia.
    Morrell D; Chase CL; Swift M
    Cancer Genet Cytogenet; 1990 Nov; 50(1):119-23. PubMed ID: 2253179
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Absence of linkage to the ataxia telangiectasia locus in familial breast cancer.
    Wooster R; Ford D; Mangion J; Ponder BA; Peto J; Easton DF; Stratton MR
    Hum Genet; 1993 Aug; 92(1):91-4. PubMed ID: 8365732
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Breast cancer incidence and the effect of cigarette smoking in heterozygous carriers of mutations in the ataxia-telangiectasia gene.
    Swift M; Lukin JL
    Cancer Epidemiol Biomarkers Prev; 2008 Nov; 17(11):3188-92. PubMed ID: 18990761
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cancer predisposition of ataxia-telangiectasia heterozygotes.
    Swift M; Chase CL; Morrell D
    Cancer Genet Cytogenet; 1990 May; 46(1):21-7. PubMed ID: 2184933
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Ataxia telangiectasia: what impact in clinical oncology?].
    Stoppa-Lyonnet D; Aurias A
    Bull Cancer; 1992; 79(7):645-50. PubMed ID: 1467590
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cancer in homozygotes and heterozygotes of ataxia-telangiectasia and xeroderma pigmentosum in Britain.
    Pippard EC; Hall AJ; Barker DJ; Bridges BA
    Cancer Res; 1988 May; 48(10):2929-32. PubMed ID: 3359449
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Public health burden of cancer in ataxia-telangiectasia heterozygotes.
    Swift M
    J Natl Cancer Inst; 2001 Jan; 93(2):84-5. PubMed ID: 11208872
    [No Abstract]   [Full Text] [Related]  

  • 18. Molecular genotyping shows that ataxia-telangiectasia heterozygotes are predisposed to breast cancer.
    Athma P; Rappaport R; Swift M
    Cancer Genet Cytogenet; 1996 Dec; 92(2):130-4. PubMed ID: 8976369
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Malignant neoplasms in the families of patients with ataxia-telangiectasia.
    Swift M; Sholman L; Perry M; Chase C
    Cancer Res; 1976 Jan; 36(1):209-15. PubMed ID: 1248000
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Breast cancer and other cancers in Norwegian families with ataxia-telangiectasia.
    Børresen AL; Andersen TI; Tretli S; Heiberg A; Møller P
    Genes Chromosomes Cancer; 1990 Nov; 2(4):339-40. PubMed ID: 2268581
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.